Valuation: Tactile Systems Technology, Inc.

Capitalization 621M 529M 494M 465M 857M 56.28B 936M 5.77B 2.24B 26.53B 2.33B 2.28B 96.79B P/E ratio 2025 *
34.9x
P/E ratio 2026 * 27.8x
Enterprise value 621M 529M 494M 465M 857M 56.28B 936M 5.77B 2.24B 26.53B 2.33B 2.28B 96.79B EV / Sales 2025 *
1.94x
EV / Sales 2026 * 1.79x
Free-Float
98.05%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.45%
1 week-0.32%
Current month+8.21%
1 month+13.14%
3 months+105.92%
6 months+179.60%
Current year+62.41%
More quotes
1 week 27.4
Extreme 27.4
29.49
1 month 22.58
Extreme 22.575
29.49
Current year 8.61
Extreme 8.6098
29.49
1 year 8.61
Extreme 8.6098
29.49
3 years 8.61
Extreme 8.6098
29.49
5 years 6.28
Extreme 6.28
64.53
10 years 6.28
Extreme 6.28
76.63
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2024
Director of Finance/CFO 50 19/03/2023
Chief Operating Officer - 31/10/2021
Director TitleAgeSince
Chairman 65 31/08/2015
Director/Board Member 66 19/09/2017
Director/Board Member 59 31/12/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.45%-0.32%+53.45%+154.06% 621M
-0.01%+0.01%+0.01%+54.51% 12.57B
+0.20%+3.78%+23.69%+44.88% 12.22B
-2.08%-2.36%-20.98%-3.50% 7.43B
+0.53%-0.43%+22.02%-12.56% 6.17B
+1.62%-0.75%+15.34%+19.42% 5.17B
+1.74%-1.05%+1.71%-1.84% 5.06B
+2.43%-1.33%-5.62%+74.40% 4.76B
+0.05%-.--%+41.92%+14.80% 4.7B
-3.24%-5.53%+42.36%-17.04% 1.92B
Average -0.02%-0.72%+17.39%+32.71% 6.06B
Weighted average by Cap. +0.20%+0.06%+10.59%+28.18%
See all sector performances

Financials

2025 *2026 *
Net sales 320M 272M 254M 239M 441M 28.96B 481M 2.97B 1.15B 13.65B 1.2B 1.17B 49.8B 348M 296M 277M 261M 480M 31.51B 524M 3.23B 1.25B 14.86B 1.31B 1.28B 54.2B
Net income 18.36M 15.64M 14.61M 13.75M 25.31M 1.66B 27.65M 171M 66.15M 784M 68.89M 67.44M 2.86B 22.65M 19.29M 18.02M 16.96M 31.22M 2.05B 34.1M 210M 81.6M 967M 84.98M 83.19M 3.53B
Net Debt - -
More financial data * Estimated data
Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Employees
1,037
More about the company
Date Price Change Volume
12/12/25 27.82 $ -1.45% 438,016
11/12/25 28.23 $ -1.88% 429,760
10/12/25 28.77 $ +0.95% 672,508
09/12/25 28.50 $ +2.70% 351,366
08/12/25 27.75 $ -0.57% 327,575

Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.82USD
Average target price
24.00USD
Spread / Average Target
-13.73%
Consensus

Quarterly revenue - Rate of surprise